Synchron has been published in multiple peer-reviewed journals including JAMA Neurology, Nature Biotechnology, Nature Biomedical Engineering, and JNIS. Synchron is based in Brooklyn, New York with R&D ...
NEW YORK--(BUSINESS WIRE)--Synchron, a category-defining brain-computer interface (BCI) company, announced today a step forward in implantable BCI technology to drive the future of neurotechnology.
Medical device leaders who have built and scaled category-defining products join Synchron to help drive its next-generation brain-computer interface platform as well as accelerate towards ...
Synchron’s brain-computer interface device is being developed to allow patients with mobility challenges to operate certain technology with their mind. Synchron, a brain-computer interface (BCI) ...
NEW YORK--(BUSINESS WIRE)--#BCI--Synchron, the brain-computer interface (BCI) company developing endovascular technology to restore functionality in patients with motor impairment, today announced the ...
Neurotech firm Synchron has integrated OpenAI’s generative AI tech into its brain-computer interface to help severely paralyzed patients communicate again. Patients suffering from severe neurological ...
Synchron, a brain-computer interface (BCI) company, has unveiled the roadmap to Chiral, which the company describes as “a foundation model of human cognitions, marking the emergence of Cognitive AI.” ...
IFLScience needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results